Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice

European Journal of Pharmacology

Volumn 462, Issue 1-3, 2003, Pages 125-132

  Hildebrandt, Audrey L ^a   Kelly Sullivan, Dawn M ^a   Black, Shawn C ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

AM 251; Anorectic; Cannabinoid; Micro CT; Obesity

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; AMIDE; ANTIOBESITY AGENT; CANNABINOID; CANNABINOID 1 RECEPTOR; DRUG VEHICLE; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIET; DRUG EFFECT; DRUG EFFICACY; FOOD INTAKE; HYPERPHAGIA; INGUINAL REGION; LONG TERM CARE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS FAT;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CHOLESTEROL; DIETARY FATS; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; INSULIN; LEPTIN; MALE; MICE; MICE, INBRED C57BL; OBESITY; PIPERIDINES; PYRAZOLES; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; TRIGLYCERIDES;

EID: 0037458690     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01343-8     Document Type: Article

References (26)

1. Arnone M., Maruani J., Chaperon F., Thiebot M.H., Poncelet M., Soubrie P., Le Fur G. Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology (Berl.). 132:1997;104-106.
2. Colombo G., Agabio R., Diaz G., Lobina C., Reali R., Gessa G.L. Appetite suppression and weight loss after the cannabinoid antagonist SR 141716. Life Sci. 63:1998;L113-L117.
3. Connolly H.M., Crary J.L., McGoon M.D., Hensrud D.D., Edwards B.S., Edwards W.D., Schaff H.V. Valvular heart disease associated with fenfluramine-phentermine. N. Engl. J. Med. 337:1997;581-588.
4. Derry S., Pritchard-Copley A. Appetite suppressants and valvular heart disease - a systematic review. BMC Clin. Pharmacol. 2:2002;6.
5. Di-Marzo V., Goparaju S.K., Wang L., Liu J., Batkai S., Jarai Z., Fezza F., Miura G.I., Palmiter R.D., Sugiura T., Kunos G. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature. 410:2001;822-825.
6. Foltin R.W., Fischman M.W., Byrne M.F. Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory. Appetite. 11:1988;1-14.
7. Gardiner S.M., March J.E., Kemp P.A., Bennett T. Complex regional haemodynamic effects of anandamide in conscious rats. Br. J. Pharmacol. 135:2002;1889-1896.
8. Gatley S.J., Gifford A.N., Volkow N.D., Lan R., Makriyannis A. 123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors. Eur. J. Pharmacol. 307:1996;331-338.
9. Gatley S.J., Lan R., Pyatt B., Gifford A.N., Volkow N.D., Makriyannis A. Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptors. Life Sci. 61:1997;L-7.
10. Hanus L., Abu-Lafi S., Fride E., Breuer A., Vogel Z., Shalev D.E., Kustanovich I., Mechoulam R. 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. Proc. Natl. Acad. Sci. U. S. A. 98:2001;3662-3665.
11. Hildebrandt A.L., Kelly-Sullivan D.M., Black S.C. Validation of a high-resolution X-ray computed tomography system to measure murine adipose tissue depot mass in situ and longitudinally. J. Pharmacol. Toxicol. Methods. 47:2002;99-106.
12. Howlett A.C., Barth F., Bonner T.I., Cabral G., Casellas P., Devane W.A., Felder C.C., Herkenham M., Mackie K., Martin B.R., Mechoulam R., Pertwee R.G. International Union of Pharmacology: XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 54:2002;161-202.
13. James P.T., Leach R., Kalamara E., Shayeghi M. The worldwide obesity epidemic. Obes. Res. 9(Suppl. 4):2001;228S-233S.
14. Jamshidi N., Taylor D.A. Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. Br. J. Pharmacol. 134:2001;1151-1154.
15. Kirkham T.C., Williams C.M., Fezza F., Di M.V. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br. J. Pharmacol. 136:2002;550-557.
16. Lan R., Liu Q., Fan P., Lin S., Fernando S.R., McCallion D., Pertwee R., Makriyannis A. Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists. J. Med. Chem. 42:1999;769-776.
17. Levin B.E., Dunn-Meynell A.A., Balkan B., Keesey R.E. Selective breeding for diet-induced obesity and resistance in Sprague-Dawley rats. Am. J. Physiol. 273:1997;R725-R730.
18. Maffei M., Halaas J., Ravussin E., Pratley R.E., Lee G.H., Zhang Y., Fei H., Kim S., Lallone R., Ranganathan S. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat. Med. 1:1995;1155-1161.
19. Porter A.C., Sauer J.M., Knierman M.D., Becker G.W., Berna M.J., Bao J., Nomikos G.G., Carter P., Bymaster F.P., Leese A.B., Felder C.C. Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. J. Pharmacol. Exp. Ther. 301:2002;1020-1024.
20. Ravinet T.C., Arnone M., Delgorge C., Gonalons N., Keane P., Maffrand J.P., Soubrie P. Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice. Am. J. Physiol., Regul. Integr. Comp. Physiol. 284:2003;R345-R353.
21. Rinaldi-Carmona M., Barth F., Heaulme M., Shire D., Calandra B., Congy C., Martinez S., Maruani J., Neliat G., Caput D. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350:1994;240-244.
22. Simiand J., Keane M., Keane P.E., Soubrie P. SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset. Behav. Pharmacol. 9:1998;179-181.
23. Vagelos R., Jacobs M., Popp R.L., Liang D. Reversal of Phen-Fen associated valvular regurgitation documented by serial echocardiography. J. Am. Soc. Echocardiogr. 15:2002;653-657.
24. Van der Ploeg L.H. Obesity: an epidemic in need of therapeutics. Curr. Opin. Chem. Biol. 4:2000;452-460.
25. Williams C.M., Kirkham T.C. Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors. Psychopharmacology (Berl.). 143:1999;315-317.
26. Williams C.M., Rogers P.J., Kirkham T.C. Hyperphagia in pre-fed rats following oral delta9-THC. Physiol. Behav. 65:1998;343-346.